Ipragliflozin is a glycoside under investigation for its role in pharmaceutical manufacturing, particularly in the context of type 2 diabetes research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ipragliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ipragliflozin L-proline
pharmaceutical raw material
Meldonium
pharmaceutical raw material
Acidihydroergocristine
pharmaceutical raw material
Lobeglitazone sulfate
pharmaceutical raw material
Olaparib
pharmaceutical raw material
(1S)-1,5-Anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol 2,3,4,6-tetraacetate
research compound
The international HS code for Ipragliflozin (CAS 761423-87-4) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
AHFWIQIYAXSLBA-RQXATKFSSA-N
C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)F
Sourcing Ipragliflozin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.